G. Abongomera

发表

Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda

J. Seeley, A. Phillips, P. Revill, 2015, BMC Health Services Research.

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

N. Klein, F. Fitzgerald, A. Sarah Walker, 2019 .

Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study

J. Seeley, P. Revill, H. Namata, 2016, BMC Health Services Research.

Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study

C. Kityo, F. Bajunirwe, P. Mugyenyi, 2019, PloS one.

Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study

C. Kityo, F. Bajunirwe, P. Mugyenyi, 2019, bioRxiv.

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

P. Easterbrook, H. Namata, A. Siika, 2018, The Lancet. Infectious diseases.

Adherence to combination antiretroviral therapy in complex emergency settings

S. Jacob, G. Abongomera, 2009, BMJ : British Medical Journal.

Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.

J. Seeley, S. Kiwuwa-Muyingo, E. Katabira, 2019, International health.

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts

C. Kityo, F. Bajunirwe, P. Mugyenyi, 2018, BioMed research international.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

P. Easterbrook, T. Peto, N. French, 2017, The lancet. HIV.

Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa

A. Walker, V. Mulenga, C. Kityo, 2016, AIDS and Behavior.

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial

A. Walker, N. Klein, V. Mulenga, 2016, The Lancet. Infectious diseases.

Pharmacokinetics of Abacavir and its Anabolite Carbovir Triphosphate without and with Darunavir/ Ritonavir or Raltegravir in HIV-Infected Subjects

B. Gazzard, S. Khoo, M. Boffito, 2012, Antiviral therapy.

Anthropometric Measurements and Lipid Profiles to Detect Early Lipodystrophy in Antiretroviral Therapy Experienced HIV-Infected Children in the Chapas-3 Trial

N. Klein, V. Mulenga, D. Gibb, 2014, Antiviral therapy.

Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda.

F. Ssali, C. Kityo, R. Colebunders, 2012, AIDS research and human retroviruses.

Lablite: baseline mapping survey of decentralised ART service provision in Malawi, Uganda and Zimbabwe.

J. Seeley, P. Revill, H. Namata, 2012 .

A high prevalence of hepatitis B virus infection in pregnant, South-South migrating African women: The need for routine screening, vaccination and follow up.

B. Castelnuovo, P. Ocama, C. Orach, 2020, Travel medicine and infectious disease.

Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda

C. Kityo, F. Bajunirwe, P. Mugyenyi, 2016, BMC Research Notes.

The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe

J. Seeley, P. Revill, H. Namata, 2014, BMC Health Services Research.

Most HIV-infected individuals on antiretroviral therapy ( ART ) in low and middle-income countries are treated following the World Health

J. Seeley, P. Revill, H. Namata, 2014 .

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.

P. Easterbrook, A. Siika, A. Kambugu, 2014, The New England journal of medicine.

Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda

C. Kityo, F. Bajunirwe, P. Mugyenyi, 2016, BMC Research Notes.

Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and Uganda.

J. Seeley, P. Revill, C. Gilks, 2018, International health.

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

J. Seeley, K. Maitland, A. Shali, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys.

J. Seeley, A. Phillips, P. Revill, 2017, International health.

Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience

J. Seeley, C. Gilks, E. Katabira, 2017, Journal of acquired immune deficiency syndromes.

Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study

J. Fehr, B. Castelnuovo, A. Kambugu, 2021, BMC Infectious Diseases.

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

P. Easterbrook, N. French, H. Namata, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV

F. Fitzgerald, A. Sarah Walker, V. Mulenga, 2018, The Journal of infectious diseases.

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.

P. Easterbrook, A. Siika, A. Kambugu, 2014, The New England journal of medicine.